• Find an Expert
  • Contact
  • SearchSearch icon
  • Menu
  • Help
  • Report an issue

Journal article

Stereotactic ablative body radiotherapy for primary kidney cancer: What have we learned from prospective trials and what does the future hold?

S Siva, CP Daniels, RJ Ellis, L Ponsky, SS Lo

Future Oncology | FUTURE MEDICINE LTD | Published : 2016

DOI: 10.2217/fon.16.6

University of Melbourne Researchers

Shankar Siva's Profile Picture
Shankar Siva Author

Christopher Daniels's Profile Picture
Christopher Daniels Author

Grants

Citation metrics

6Scopus
4Web of Science
6Dimensions

Keywords

Clinical Trials
Renal-Cell Carcinoma
Life Sciences & Biomedicine
Science & Technology
Sbrt
Cancer
6.5 Radiotherapy and Other Non-Invasive Therapies
Radiation
Oncology
Mass
32 Biomedical and Clinical Sciences
Health Disparities and Racial Or Ethnic Minority Health Research
Kidney Disease
3211 Oncology and Carcinogenesis
Radiation Oncology
Renal Cell Carcinoma
Rare Diseases
Survival

Acknowledgement of Country

We acknowledge Aboriginal and Torres Strait Islander people as the Traditional Owners of the unceded lands on which we work, learn and live. We pay respect to Elders past, present and future, and acknowledge the importance of Indigenous knowledge in the Academy.

Read about our Indigenous priorities

About us  

Careers at Melbourne  

Safety and respect  

Newsroom  

Contact  

Campus locations  

Phone: 13 MELB ( 13 6352)

International: +61 3 9035 5511


Address:
The University of Melbourne
Grattan Street, Parkville,
Victoria, 3010, Australia

facebookIconlinkedinIconinstagramIcon

Emergency information  |  Disclaimer and copyright  |  Accessibility  |  Privacy

CRICOS number: 00116K     ABN: 84 002 705 224